Global Dermatology Device Market Overview

The global dermatology device market is projected to expand significantly, increasing from US$ 5,408.57 million in 2021 to US$ 11,235.42 million by 2028. This growth represents a compound annual growth rate (CAGR) of 11.2% from 2022 to 2028. The report outlines the prevailing trends in the market and identifies key factors contributing to its expansion.

Market Growth Drivers

The surge in the global dermatology device market can be primarily linked to the increasing number of aesthetic procedures conducted annually. However, challenges such as complications arising from cancer treatments and cosmetic surgeries performed by inadequately trained professionals pose significant barriers to market growth.

Role of Dermatology Devices

Dermatology encompasses a broad spectrum of medical devices utilized for both cosmetic and medical purposes. These devices are essential for diagnosing and treating various skin conditions, including skin cancer, psoriasis, and more. They are also employed in procedures such as cryosurgery, photodynamic therapy, Mohs micrographic surgery, and electrodesiccation & curettage. The Food and Drug Administration (FDA) plays a vital role in regulating, approving, and monitoring the safety and effectiveness of these devices.

Skin Rejuvenation and Resurfacing

According to a report by the American Society of Plastic Surgeons (ASPS), unprotected exposure to ultraviolet (UV) rays, along with aging and genetic factors, can lead to various skin irregularities. These irregularities may manifest as textural issues like wrinkles and acne scars, as well as pigmentation changes such as freckles and sunspots. Additionally, these conditions can result in a loss of skin tone and firmness, which are characteristic of youthful skin.

To address these skin irregularities and repair skin damage, a variety of treatment options are available in the market. These include laser treatments for skin resurfacing, mechanical resurfacing, chemical peels, and injectable products aimed at reducing the appearance of fine lines and wrinkles. Advanced treatment modalities are also effective for pigmentation disorders and acne scars. For instance, laser resurfacing is a facial rejuvenation technique that utilizes lasers to enhance skin appearance or correct minor facial imperfections. This procedure can be categorized into two types: Ablative Lasers and Nonablative Lasers. Ablative lasers remove the outer skin layer while heating the underlying dermis to stimulate collagen production. Common types of ablative lasers include carbon dioxide lasers and erbium lasers. In contrast, nonablative lasers are less invasive, offering shorter recovery times. Consequently, skin rejuvenation and resurfacing are anticipated to be significant trends driving the growth of the dermatology devices market in the coming years.

Market Segmentation

The dermatology devices market is categorized based on product type into treatment devices and diagnostic devices. The treatment device segment dominated the market share in 2021 and is expected to exhibit a higher CAGR from 2022 to 2028. Furthermore, the market is segmented by application into skin cancer diagnosis, skin rejuvenation, hair removal, body contouring & skin tightening, psoriasis, and others. The skin cancer diagnosis segment held the largest market share in 2021 and is projected to continue its growth through 2028. In terms of end users, the market is divided into hospitals, dermatology clinics, and others, with hospitals holding the largest market share in 2021. However, dermatology clinics are expected to experience significant growth during the forecast period.

Impact of COVID-19 on the Dermatology Device Market

The Indian Journal of Dermatology reported that the COVID-19 pandemic created substantial challenges for the healthcare system, particularly affecting dermatology procedures. Elective and cosmetic procedures were postponed, prioritizing urgent dermatological needs to minimize the risk of SARS-CoV-2 transmission in healthcare settings, especially in North America. Dermatologists faced a high risk of COVID-19 exposure due to close patient contact. Despite these challenges, the role of dermatologists remained crucial as procedural dermatology and aesthetic surgery are integral to their practice. These factors contributed to a slowdown in the growth of dermatology devices during the pandemic, but the market is expected to rebound with promising opportunities in the future.

Strategic Developments in the Market

Companies in the global dermatology device market are employing various organic and inorganic strategies to enhance their market presence. Organic strategies primarily involve product launches and approvals, while inorganic strategies include acquisitions, collaborations, and partnerships. These strategies enable market players to expand their operations and improve their geographic reach, thereby fostering overall market growth. Notable developments in the dermatology device market include:

• In July 2022, Lumenis received a CE mark for Splendor X, a device for hair removal and treatment of vascular lesions and wrinkles, utilizing BLEND X technology.


• In May 2021, Lumenis partnered with Harrods Wellness Clinic in London to equip its aesthetic clinic with the Stellar M22 platform.


• In March 2021, Leica Microsystems acquired Aivia from SVision LLC to enhance its portfolio of opto-digital solutions.


• In March 2022, Cynosure announced a partnership with Jeisys Medical KK to advance energy-based aesthetic devices in Japan.

Key sources for this report include the American Medical Association, the British Journal of Surgery, and the National Library of Medicine.